A simulation study of outcome adaptive randomization in multi-arm clinical trials

Clinical Trials

Volumn 14, Issue 5, 2017, Pages 432-440

  Wathen, J Kyle ^a   Thall, Peter F ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adaptive randomization; Bayesian design; play the winner; screening trial; simulation

Indexed keywords

ADAPTIVE RANDOMIZATION; BAYES THEOREM; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DECISION MAKING; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; SAMPLE SIZE; SIMULATION; VALIDATION PROCESS; CASE CONTROL STUDY; COMPUTER SIMULATION; EVALUATION STUDY; METHODOLOGY; PATIENT SELECTION; PROCEDURES;

BAYES THEOREM; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RANDOM ALLOCATION; RESEARCH DESIGN; SAMPLE SIZE;

EID: 85028966104     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774517692302     Document Type: Conference Paper

References (25)

1. Thompson WR., On the likelihood that one unknown probability exceeds another in view of the evidence of the two samples. Biometrika 1933; 25: 285-294.
2. Wei LJ, Durham S., The randomized play-the-winner rule in medical trials. J Am Stat Assoc 1978; 73: 840-843.
3. Zelen M., A new design for randomized clinical trials. N Engl J Med 1979; 300: 1242-1246.
4. Cheung YK, Inoue LYT, Wathen JK, et al. Continuous Bayesian adaptive randomization based on event times with covariates. Stat Med 2006; 25: 55-70.
5. Thall PF, Wathen JK., Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments. Stat Med 2005; 24: 1947-1964.
6. Hu F, Rosenberger WF., The theory of response-adaptive randomization in clinical trials (Wiley series in probability and statistics). Hoboken, NJ: John Wiley & Sons, 2006.
7. Sverdlov O., Modern adaptive randomized clinical trials: statistical and practical aspects. Boca Raton, FL: CRC Press, 2015.
8. Giles FJ, Kantarjian HM, Cortes JE, et al. Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia. J Clin Oncol 2003; 21: 1722-1727.
9. Maki RG, Wathen JK, Hensley ML, et al. An adaptively randomized phase III study of gemcitabine and docetaxel versus gemcitabine alone in patients with metastatic soft-tissue sarcomas. J Clin Oncol 2007; 25: 2755-1763.
10. Kim ES, Herbsy RS, Wistuba II, et al. The battle trial: personalizing therapy for lung cancer. Cancer Discov 2011; 1: 44-53.
11. Chappell R, Karrison T., Letter to the editor. Stat Med 2007; 26: 3046-3056.
12. Korn EL, Freidlin B., Outcome-adaptive randomization: is it useful? J Clin Oncol 2011; 29: 771-776.
13. Yuan Y, Yin G., On the usefulness of outcome-adaptive randomization. J Clin Oncol 2011; 29: 390-392.
14. Lee JJ, Chen N, Yin G., Worth adapting? Revisiting the usefulness of outcome-adaptive randomization. Clin Cancer Res 2012; 18: 4498-4507.
15. Rosenberger WF, Sverdlov O, Hu F., Adaptive randomization for clinical trials. JBS 2012; 22: 719-36.
16. Buyse M., Commentary on Hey and Kimmelman. Clin Trials 2015; 12: 119-121.
17. Lee JJ., Commentary on Hey and Kimmelman. Clin Trials 2015; 12: 110-112.
18. Hey SP, Kimmellman J., Are outcome-adaptive allocation trials ethical? Clin Trials 2015; 12: 102-106.
19. Thall PF, Fox PS, Wathen JK., Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials. Ann of Oncol 2015; 26: 1621-1628.
20. Berry DA., Adaptive clinical trials: the promise and the caution. J Clin Oncol 2011; 29: 606-609.
21. Rosenberger WR, Lachin JM., The use of response-adaptive designs in clinical trials. Control Clin Trials 1993; 14: 471-484.
22. Karrison TG, Huo D, Chappell R., A group sequential, response-adaptive design for randomized clinical trials. Control Clin Trials 2003; 24: 506-522.
23. Thall PF, Wathen JK., Practical Bayesian adaptive randomization in clinical trials. EJC 2007; 43: 860-867.
24. Sutton RS, Barto AG., Reinforcement learning: an introduction. Cambridge, MA: MIT Press, 1998.
25. Berry SM, Connor JT, Lewis RJ., The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015; 313: 1619-1620.